Login / Signup

Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations.

Hironari HanaokaHarunobu IidaTomofumi KiyokawaYukiko TakakuwaKimito Kawahata
Published in: Clinical rheumatology (2019)
Our results suggest that the cessation of all drugs is associated with disease flare for SLE patients without major organ manifestations. IS or HCQ monotherapy might be a reasonable maintenance strategy comparing with steroid monotherapy. Key Point • Immunosuppressant or hydroxychloroquine monotherapy appears to be a reasonable maintenance strategy.
Keyphrases
  • combination therapy
  • open label
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • systemic lupus erythematosus
  • peritoneal dialysis
  • clinical trial
  • rheumatoid arthritis
  • patient reported outcomes